Pulmonary drug delivery (AlphazerTM)

Overview
Pulmonary drug delivery (the inhalation of drugs into the lungs through the oral cavity) is a promising route for the delivery of medications both locally to the lungs and to the systemic circulation. Current inhalation devices suffer from low efficiency and other limitations. None combine high efficacy, portability and convenience with inter- and intra-patient dosage accuracy, and few are suitable for delivery of biologics.
Read more ...

Description of our technology
Omega Life Science developed a pulmonary drug delivery system for systemic and local targeting, consisting of a propriety inhaler and a tailor-made formulation technology. The inhaler employs our ability to produce sub-micron droplets and sub-micron to nano- sized dry particles (link to Description of our Technology).
Read more ...

The Inhaler
Omega Life Science's aerosolization technology enabled the development of a proprietary inhaler (AlphazerTM) for the inhalation of ultra-fine aerosol (dry or wet) with unprecedented small particle size and high particles density.
Read more ...

Target markets
In the pulmonary drug delivery market, Omega Life Science addresses the following sub-categories:
Drugs that are currently administered by injection, Oral drugs with liver-toxicity or gastrointestinal uptake issues, Drugs administered in large doses that currently require long...
Read more ...